{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:22:10Z","timestamp":1783642930901,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82074289, 81673840, 82104705"],"award-info":[{"award-number":["82074289, 81673840, 82104705"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M741603"],"award-info":[{"award-number":["2023M741603"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020A1515110651"],"award-info":[{"award-number":["2020A1515110651"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Medical Science and Technology Research Foundation","award":["A2021476"],"award-info":[{"award-number":["A2021476"]}]},{"name":"Traditional Chinese Medicine Research Project of Guangdong Province Traditional Chinese Medicine Bureau","award":["20221256"],"award-info":[{"award-number":["20221256"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-026-00968-1","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T03:46:52Z","timestamp":1778471212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MiR-4788 promotes NSCLC progression by targeting DLG5 to enhance mitochondrial function"],"prefix":"10.1186","volume":"20","author":[{"given":"Yanting","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baizhao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"968_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"968_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1470-2045(21)00630-6","volume":"23","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, et al. Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial. Lancet Oncol. 2022;23:209\u201319. https:\/\/doi.org\/10.1016\/S1470-2045(21)00630-6.","journal-title":"Lancet Oncol"},{"key":"968_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1053\/j.semdp.2021.04.001","volume":"38","author":"E Paver","year":"2021","unstructured":"Paver E, O\u2019Toole S, Cheng XM, Mahar A, Cooper WA. Updates in the molecular pathology of non-small cell lung cancer. Semin Diagn Pathol. 2021;38:54\u201361. https:\/\/doi.org\/10.1053\/j.semdp.2021.04.001.","journal-title":"Semin Diagn Pathol"},{"key":"968_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pharmthera.2019.06.005","volume":"202","author":"M Terlizzi","year":"2019","unstructured":"Terlizzi M, Colarusso C, Pinto A, Sorrentino R. Drug resistance in non-small cell lung Cancer (NSCLC): Impact of genetic and non-genetic alterations on therapeutic regimen and responsiveness. Pharmacol Ther. 2019;202:140\u20138. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.06.005.","journal-title":"Pharmacol Ther"},{"key":"968_CR5","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.2147\/DDDT.S194231","volume":"13","author":"D Lavacchi","year":"2019","unstructured":"Lavacchi D, Mazzoni F, Giaccone G. Clinical evaluation of dacomitinib for the treatment of metastatic non-small cell lung cancer (NSCLC): current perspectives. Drug Des Devel Ther. 2019;13:3187\u201398. https:\/\/doi.org\/10.2147\/DDDT.S194231.","journal-title":"Drug Des Devel Ther"},{"key":"968_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.lungcan.2020.11.013","volume":"152","author":"S Lu","year":"2021","unstructured":"Lu S, et al. Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer: 2-year follow-up from a randomized, open-label, phase 3 study (CheckMate 078). Lung Cancer. 2021;152:7\u201314. https:\/\/doi.org\/10.1016\/j.lungcan.2020.11.013.","journal-title":"Lung Cancer"},{"key":"968_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-017-0718-4","volume":"16","author":"F Yang","year":"2017","unstructured":"Yang F, et al. Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts. Mol Cancer. 2017;16:148. https:\/\/doi.org\/10.1186\/s12943-017-0718-4.","journal-title":"Mol Cancer"},{"key":"968_CR8","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1007\/s00018-015-1922-2","volume":"72","author":"F Afonso-Grunz","year":"2015","unstructured":"Afonso-Grunz F, Muller S. Principles of miRNA-mRNA interactions: beyond sequence complementarity. Cell Mol Life Sci. 2015;72:3127\u201341. https:\/\/doi.org\/10.1007\/s00018-015-1922-2.","journal-title":"Cell Mol Life Sci"},{"key":"968_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235782","author":"H Saman","year":"2022","unstructured":"Saman H, Raza A, Patil K, Uddin S, Crnogorac-Jurcevic T Non-Invasive Biomarkers for Early Lung Cancer Detection. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14235782.","journal-title":"Cancers (Basel)"},{"key":"968_CR10","doi-asserted-by":"publisher","first-page":"e23003","DOI":"10.1002\/jcla.23003","volume":"33","author":"Q He","year":"2019","unstructured":"He Q, et al. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer. J Clin Lab Anal. 2019;33:e23003. https:\/\/doi.org\/10.1002\/jcla.23003.","journal-title":"J Clin Lab Anal"},{"key":"968_CR11","doi-asserted-by":"publisher","first-page":"702695","DOI":"10.3389\/fgene.2021.702695","volume":"12","author":"FM Hsieh","year":"2021","unstructured":"Hsieh FM, Lai ST, Wu MF, Lin CC. Identification and Elucidation of the Protective isomiRs in Lung Cancer Patient Prognosis. Front Genet. 2021;12:702695. https:\/\/doi.org\/10.3389\/fgene.2021.702695.","journal-title":"Front Genet"},{"key":"968_CR12","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1136\/gutjnl-2020-320652","volume":"70","author":"L Sun","year":"2021","unstructured":"Sun L, et al. RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer. Gut. 2021;70:1698\u2013712. https:\/\/doi.org\/10.1136\/gutjnl-2020-320652.","journal-title":"Gut"},{"key":"968_CR13","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1038\/s41467-018-06655-7","volume":"9","author":"K Ni","year":"2018","unstructured":"Ni K, et al. Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy. Nat Commun. 2018;9:4321. https:\/\/doi.org\/10.1038\/s41467-018-06655-7.","journal-title":"Nat Commun"},{"key":"968_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13046-022-02304-6","volume":"41","author":"M Zamberlan","year":"2022","unstructured":"Zamberlan M, et al. Inhibition of the mitochondrial protein Opa1 curtails breast cancer growth. J Exp Clin Cancer Res. 2022;41:95. https:\/\/doi.org\/10.1186\/s13046-022-02304-6.","journal-title":"J Exp Clin Cancer Res"},{"key":"968_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147897","author":"A Wagner","year":"2022","unstructured":"Wagner A, Kosnacova H, Chovanec M, Jurkovicova D Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential. Int J Mol Sci. 2022. . https:\/\/doi.org\/10.3390\/ijms23147897.","journal-title":"Int J Mol Sci"},{"key":"968_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13046-022-02447-6","volume":"41","author":"IC Salaroglio","year":"2022","unstructured":"Salaroglio IC, et al. Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer. J Exp Clin Cancer Res. 2022;41:243. https:\/\/doi.org\/10.1186\/s13046-022-02447-6.","journal-title":"J Exp Clin Cancer Res"},{"key":"968_CR17","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.21037\/jtd-21-752","volume":"13","author":"J Che","year":"2021","unstructured":"Che J, et al. Decreased expression of Dlg5 is associated with a poor prognosis and epithelial-mesenchymal transition in squamous cell lung cancer. J Thorac Dis. 2021;13:3115\u201325. https:\/\/doi.org\/10.21037\/jtd-21-752.","journal-title":"J Thorac Dis"},{"key":"968_CR18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.7150\/ijbs.8888","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Li J, Ren Y, Liu P. DLG5 in cell polarity maintenance and cancer development. Int J Biol Sci. 2014;10:543\u20139. https:\/\/doi.org\/10.7150\/ijbs.8888.","journal-title":"Int J Biol Sci"},{"key":"968_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10555-008-9169-0","volume":"28","author":"M Yilmaz","year":"2009","unstructured":"Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009;28:15\u201333. https:\/\/doi.org\/10.1007\/s10555-008-9169-0.","journal-title":"Cancer Metastasis Rev"},{"key":"968_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3389\/fphar.2020.00271","volume":"11","author":"Y You","year":"2020","unstructured":"You Y, et al. Silibinin Induces G2\/M Cell Cycle Arrest by Activating Drp1-Dependent Mitochondrial Fission in Cervical Cancer. Front Pharmacol. 2020;11:271. https:\/\/doi.org\/10.3389\/fphar.2020.00271.","journal-title":"Front Pharmacol"},{"key":"968_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.lungcan.2022.03.004","volume":"166","author":"NJ Robert","year":"2022","unstructured":"Robert NJ, et al. Biomarker testing and tissue journey among patients with metastatic non-small cell lung cancer receiving first-line therapy in The US Oncology Network. Lung Cancer. 2022;166:197\u2013204. https:\/\/doi.org\/10.1016\/j.lungcan.2022.03.004.","journal-title":"Lung Cancer"},{"key":"968_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jtho.2021.01.1621","volume":"16","author":"JK Yun","year":"2021","unstructured":"Yun JK, et al. A Validation Study of the Recommended Change in Residual Tumor Descriptors Proposed by the International Association for the Study of Lung Cancer for Patients With pN2 NSCLC. J Thorac Oncol. 2021;16:817\u201326. https:\/\/doi.org\/10.1016\/j.jtho.2021.01.1621.","journal-title":"J Thorac Oncol"},{"key":"968_CR23","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S1470-2045(20)30111-X","volume":"21","author":"SB Goldberg","year":"2020","unstructured":"Goldberg SB, et al. Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial. Lancet Oncol. 2020;21:655\u201363.","journal-title":"Lancet Oncol"},{"key":"968_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.trsl.2020.11.012","volume":"230","author":"S Zhong","year":"2021","unstructured":"Zhong S, Golpon H, Zardo P, Borlak J. miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer. Transl Res. 2021;230:164\u201396. https:\/\/doi.org\/10.1016\/j.trsl.2020.11.012.","journal-title":"Transl Res"},{"key":"968_CR25","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1182\/blood-2016-09-742296","volume":"129","author":"S Manier","year":"2017","unstructured":"Manier S, et al. Prognostic role of circulating exosomal miRNAs in multiple myeloma. Blood. 2017;129:2429\u201336. https:\/\/doi.org\/10.1182\/blood-2016-09-742296.","journal-title":"Blood"},{"key":"968_CR26","doi-asserted-by":"publisher","first-page":"6259","DOI":"10.1007\/s11033-012-1446-x","volume":"39","author":"MY Barozai","year":"2012","unstructured":"Barozai MY. The novel 172 sheep (Ovis aries) microRNAs and their targets. Mol Biol Rep. 2012;39:6259\u201366. https:\/\/doi.org\/10.1007\/s11033-012-1446-x.","journal-title":"Mol Biol Rep"},{"key":"968_CR27","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1111\/jcmm.13760","volume":"22","author":"DM Wu","year":"2018","unstructured":"Wu DM, et al. MircoRNA-1275 promotes proliferation, invasion and migration of glioma cells via SERPINE1. J Cell Mol Med. 2018;22:4963\u201374. https:\/\/doi.org\/10.1111\/jcmm.13760.","journal-title":"J Cell Mol Med"},{"key":"968_CR28","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41419-021-04238-x","volume":"12","author":"JY Liu","year":"2021","unstructured":"Liu JY, et al. LncRNA SNHG17 interacts with LRPPRC to stabilize c-Myc protein and promote G1\/S transition and cell proliferation. Cell Death Dis. 2021;12:970. https:\/\/doi.org\/10.1038\/s41419-021-04238-x.","journal-title":"Cell Death Dis"},{"key":"968_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol. 2019;29:212\u201326. https:\/\/doi.org\/10.1016\/j.tcb.2018.12.001.","journal-title":"Trends Cell Biol"},{"key":"968_CR30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/ncb3478","volume":"19","author":"A Labernadie","year":"2017","unstructured":"Labernadie A, et al. A mechanically active heterotypic E-cadherin\/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nat Cell Biol. 2017;19:224\u201337. https:\/\/doi.org\/10.1038\/ncb3478.","journal-title":"Nat Cell Biol"},{"key":"968_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1165\/rcmb.2013-0314TR","volume":"50","author":"ME Kidd","year":"2014","unstructured":"Kidd ME, Shumaker DK, Ridge KM. The role of vimentin intermediate filaments in the progression of lung cancer. Am J Respir Cell Mol Biol. 2014;50:1\u20136. https:\/\/doi.org\/10.1165\/rcmb.2013-0314TR.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"968_CR32","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1038\/s41467-020-19114-z","volume":"11","author":"C Grimaldi","year":"2020","unstructured":"Grimaldi C, et al. E-cadherin focuses protrusion formation at the front of migrating cells by impeding actin flow. Nat Commun. 2020;11:5397. https:\/\/doi.org\/10.1038\/s41467-020-19114-z.","journal-title":"Nat Commun"},{"key":"968_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41568-020-0252-3","volume":"20","author":"M Fazio","year":"2020","unstructured":"Fazio M, Ablain J, Chuan Y, Langenau DM. Zon, L. I. Zebrafish patient avatars in cancer biology and precision cancer therapy. Nat Rev Cancer. 2020;20:263\u201373. https:\/\/doi.org\/10.1038\/s41568-020-0252-3.","journal-title":"Nat Rev Cancer"},{"key":"968_CR34","doi-asserted-by":"publisher","first-page":"919424","DOI":"10.3389\/fmicb.2022.919424","volume":"13","author":"S Weber-Stiehl","year":"2022","unstructured":"Weber-Stiehl S, Jarke L, Castrillon-Betancur JC, Gilbert F, Sommer F. Mitochondrial Function and Microbial Metabolites as Central Regulators of Intestinal Immune Responses and Cancer. Front Microbiol. 2022;13:919424. https:\/\/doi.org\/10.3389\/fmicb.2022.919424.","journal-title":"Front Microbiol"},{"key":"968_CR35","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41467-020-14525-4","volume":"11","author":"X Chen","year":"2020","unstructured":"Chen X, et al. FMN reduces Amyloid-beta toxicity in yeast by regulating redox status and cellular metabolism. Nat Commun. 2020;11:867. https:\/\/doi.org\/10.1038\/s41467-020-14525-4.","journal-title":"Nat Commun"},{"key":"968_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.molcel.2015.12.002","volume":"61","author":"I Martinez-Reyes","year":"2016","unstructured":"Martinez-Reyes I, et al. TCA Cycle and Mitochondrial Membrane Potential Are Necessary for Diverse Biological Functions. Mol Cell. 2016;61:199\u2013209. https:\/\/doi.org\/10.1016\/j.molcel.2015.12.002.","journal-title":"Mol Cell"},{"key":"968_CR37","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41467-019-08393-w","volume":"10","author":"K Ruiz","year":"2019","unstructured":"Ruiz K, et al. Functional role of PGAM5 multimeric assemblies and their polymerization into filaments. Nat Commun. 2019;10:531. https:\/\/doi.org\/10.1038\/s41467-019-08393-w.","journal-title":"Nat Commun"},{"key":"968_CR38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cmet.2019.10.012","volume":"31","author":"P Huangyang","year":"2020","unstructured":"Huangyang P, et al. Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis. Cell Metab. 2020;31:174\u201388. . https:\/\/doi.org\/10.1016\/j.cmet.2019.10.012 (2020).","journal-title":"Cell Metab"},{"key":"968_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12461","author":"YQ Shen","year":"2018","unstructured":"Shen YQ, et al Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT\/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation. J Pineal Res. 2018. . https:\/\/doi.org\/10.1111\/jpi.12461.","journal-title":"J Pineal Res"},{"key":"968_CR40","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.3748\/wjg.v12.i23.3651","volume":"12","author":"F Friedrichs","year":"2006","unstructured":"Friedrichs F, Stoll M. Role of discs large homolog 5. World J Gastroenterol. 2006;12:3651\u20136. https:\/\/doi.org\/10.3748\/wjg.v12.i23.3651.","journal-title":"World J Gastroenterol"},{"key":"968_CR41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.yexcr.2014.11.015","volume":"331","author":"Z Zhou","year":"2015","unstructured":"Zhou Z, et al. Methylation-mediated silencing of Dlg5 facilitates bladder cancer metastasis. Exp Cell Res. 2015;331:399\u2013407. https:\/\/doi.org\/10.1016\/j.yexcr.2014.11.015.","journal-title":"Exp Cell Res"},{"key":"968_CR42","doi-asserted-by":"publisher","first-page":"42125","DOI":"10.1038\/srep42125","volume":"7","author":"J Liu","year":"2017","unstructured":"Liu J, et al. Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway. Sci Rep. 2017;7:42125. https:\/\/doi.org\/10.1038\/srep42125.","journal-title":"Sci Rep"},{"key":"968_CR43","first-page":"397","volume":"1","author":"X Ke","year":"2025","unstructured":"Ke X, et al. Cloud-Based GWAS Platform: An Innovative Solution for Efficient Acquisition and Analysis of Genomic Data. Med Res. 2025;1:397\u2013411.","journal-title":"Med Res"},{"key":"968_CR44","doi-asserted-by":"publisher","first-page":"e18516","DOI":"10.1111\/jcmm.18516","volume":"28","author":"P Zhang","year":"2024","unstructured":"Zhang P, et al. Integrating machine learning and single-cell analysis to uncover lung adenocarcinoma progression and prognostic biomarkers. J Cell Mol Med. 2024;28:e18516. https:\/\/doi.org\/10.1111\/jcmm.18516.","journal-title":"J Cell Mol Med"},{"key":"968_CR45","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41746-025-02172-2","volume":"8","author":"Z Gong","year":"2025","unstructured":"Gong Z, et al. Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma. NPJ Digit Med. 2025;8:796. https:\/\/doi.org\/10.1038\/s41746-025-02172-2.","journal-title":"NPJ Digit Med"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-026-00968-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00968-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00968-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:05:18Z","timestamp":1783641918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40246-026-00968-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["968"],"URL":"https:\/\/doi.org\/10.1186\/s40246-026-00968-1","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The mouse experiments were approved by the Animal Care and Use Committee of the Guangzhou Institute of Sport Science (Permit No. GZTKSGNX-2015-2).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}